HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CF PHARMTECH

20.260

-0.120-0.59%

Volume:41.00K

Turnover:833.00K

Market Cap:8.33B

PE:2.65K

High:20.660

Open:20.360

Low:20.040

Close:20.380

52wk High:48.800

52wk Low:18.100

Shares:411.00M

HK Float Shares:302.00M

Volume Ratio:0.19

T/O Rate:0.01%

Dividend:- -

Dividend Rate:- -

EPS(LYR):0.008

ROE:0.21%

ROA:-0.83%

PB:4.90

PE(LYR):2,651.49

PS:16.63

Loading ...

Overview Company News Filings

CF PharmTech Signs Three-Year Strategic Partnership with JD Health for Exclusive Online Launch of Respiratory Portfolio

Bulletin Express

CF PHARMTECH (02652) Enters Strategic Partnership with JD HEALTH

CF PharmTech Taps JD Health as Exclusive Online Partner for New Respiratory Drugs

CF PharmTech signs strategic cooperation agreement with JD Health International Inc

CF Pharmtech Inc - JD Health to Be Exclusive Online Launch Platform for Major New Products for Three Years

THOMSON REUTERS

CF PHARMTECH (02652) Forecasts 2025 Adjusted Net Profit of RMB 30-35 Million, Highlights Steady Operations and R&D Progress

CF PharmTech issues profit warning: 2025 revenue projected to fall to RMB410-450 million, net profit to narrow to RMB2-3 million

Bulletin Express

CF Pharmtech - Expected Result Due Reduction in Average Selling Price of Group's Product CF017, Others in FY

THOMSON REUTERS

CF PharmTech forecasts 2025 revenue of RMB410 million to RMB450 million and net profit of RMB2 million to RMB3 million

CF PHARMTECH (02652) Schedules 30 March 2026 Board Meeting to Approve FY 2025 Results and Final Dividend Proposal

Bulletin Express

CF PharmTech board to review FY2025 annual results and final dividend proposal

Hong Kong Market Midday Review: Hang Seng Index Dips 0.17% While AI Model Concept Stocks Climb Against Trend

CF PHARMTECH (02652) Surges Over 21% in Intraday Trading as Advanced Respiratory Pipeline Accelerates Towards Harvest Phase

CF Pharmtech IND application for ICF001 accepted by China’s NMPA

Major Milestone CF Pharmtech, Inc. 2652.HK Announces Ind Acceptance for Pah New Drug With a Globally Innovative Improved Mechanism, Marking Another Milestone for Its Precision Drug Delivery Platform

THOMSON REUTERS

BUZZ-CF PharmTech jumps most on record on new hypertension drug application

CF PHARMTECH (02652) Surges Over 17% as IND for Novel Pulmonary Hypertension Drug is Accepted

CF PHARMTECH (02652): NMPA Accepts IND Application for Inhalation-Powder Candidate ICF001

Bulletin Express

CF PHARMTECH (02652) Receives NMPA Acceptance for IND Application of Self-Developed Inhalation Powder ICF001

CF PharmTech says NMPA accepts IND application for ICF001 inhalation powder

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/02652/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02652","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02652\",,,,,undefined,":{"symbol":"02652","market":"HK","secType":"STK","nameCN":"CF PHARMTECH","latestPrice":20.26,"timestamp":1780455326208,"preClose":20.38,"halted":0,"volume":41000,"delay":0,"changeRate":-0.005888125613346293,"floatShares":302000000,"shares":411000000,"eps":0.00764133494232698,"marketStatus":"Trading","change":-0.12,"latestTime":"06-03 11:02:48","open":20.36,"high":20.66,"low":20.04,"amount":833000,"amplitude":0.030422,"askPrice":20.26,"askSize":2000,"bidPrice":20.06,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":0.00764133494232698,"tradingStatus":2,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1780459200000},"marketStatusCode":2,"adr":0,"listingDate":1759852800000,"exchange":"SEHK","adjPreClose":20.38,"openAndCloseTimeList":[[1780450200000,1780459200000],[1780462800000,1780473600000]],"volumeRatio":0.185141,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02652\",,,,,undefined,":{"symbol":"02652","floatShares":302000000,"roa":"-0.83%","roe":"0.21%","lyrEps":0.007641,"volumeRatio":0.185141,"shares":411000000,"dividePrice":0,"high":20.66,"amplitude":0.030422,"preClose":20.38,"low":20.04,"week52Low":18.1,"pbRate":"4.90","psRate":"16.63","week52High":48.8,"institutionHeld":0,"latestPrice":20.26,"committee":-0.333333,"eps":0.00764133494232698,"divideRate":0,"volume":41000,"delay":0,"ttmEps":0.00764133494232698,"open":20.36,"prevYearClose":35,"prevWeekClose":22.22,"prevMonthClose":22.22,"prevQuarterClose":22.16,"fiveDayClose":19.66,"twentyDayClose":22.02,"sixtyDayClose":37.34},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02652\",params:#limit:5,,,undefined,":[{"date":"2026-03-30","symbol":"02652","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02652\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02652\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02652\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02652","date":"2026-06-01","current":2665.19987,"percent":0.839744,"low":-293.764894,"twenty":400.575047,"median":467.575731,"eighty":2963.886694,"high":3595.964728,"avg":1098.551773,"sd":1175.771413,"marketCap":8746652155},"quantilePoints":[{"date":"2025-10-10","current":420.512992,"twenty":-8.053739,"median":420.512992,"eighty":438.465035,"marketCap":12738371726},{"date":"2025-10-17","current":400.969089,"twenty":380.917252,"median":393.18793,"eighty":412.695431,"marketCap":12136883281},{"date":"2025-10-24","current":382.04749,"twenty":383.954109,"median":395.798507,"eighty":407.879105,"marketCap":11568353106},{"date":"2025-10-31","current":411.638127,"twenty":385.87135,"median":395.798507,"eighty":410.009732,"marketCap":12482945126},{"date":"2025-11-07","current":380.629431,"twenty":385.87135,"median":397.412529,"eighty":410.009732,"marketCap":11535394836},{"date":"2025-11-14","current":413.442652,"twenty":386.82146,"median":399.24986,"eighty":411.625005,"marketCap":12565340803},{"date":"2025-11-21","current":474.663516,"twenty":387.596392,"median":401.654037,"eighty":419.1227,"marketCap":14419243545},{"date":"2025-11-28","current":513.213561,"twenty":390.697015,"median":408.734506,"eighty":451.19497,"marketCap":15646939138},{"date":"2025-12-05","current":509.365027,"twenty":391.797785,"median":411.605323,"eighty":487.699676,"marketCap":15556303893},{"date":"2025-12-12","current":478.26383,"twenty":394.588712,"median":413.442652,"eighty":485.541496,"marketCap":14633472306},{"date":"2025-12-19","current":468.273561,"twenty":396.041553,"median":429.606948,"eighty":482.974301,"marketCap":14361566570},{"date":"2025-12-24","current":469.497744,"twenty":396.770692,"median":439.211078,"eighty":482.563912,"marketCap":14443962248},{"date":"2026-01-02","current":452.984556,"twenty":397.492287,"median":451.385447,"eighty":481.570975,"marketCap":13990786022},{"date":"2026-01-09","current":417.797013,"twenty":398.674444,"median":438.955991,"eighty":480.057858,"marketCap":12936121351},{"date":"2026-01-16","current":442.060347,"twenty":399.985866,"median":432.778937,"eighty":478.730146,"marketCap":13731858722},{"date":"2026-01-23","current":466.639698,"twenty":400.772068,"median":439.902936,"eighty":477.371374,"marketCap":14481468286},{"date":"2026-01-30","current":480.840623,"twenty":401.791027,"median":446.916666,"eighty":477.757159,"marketCap":14990389486},{"date":"2026-02-06","current":464.022312,"twenty":403.190746,"median":452.185001,"eighty":477.033593,"marketCap":14502764350},{"date":"2026-02-13","current":452.173894,"twenty":406.744138,"median":454.320794,"eighty":475.6532,"marketCap":14213623359},{"date":"2026-02-20","current":472.094804,"twenty":408.734506,"median":454.916554,"eighty":476.776403,"marketCap":14818441932},{"date":"2026-02-27","current":505.751529,"twenty":411.273773,"median":459.838493,"eighty":479.42962,"marketCap":16048983093},{"date":"2026-03-06","current":445.246344,"twenty":411.572519,"median":460.887466,"eighty":481.94993,"marketCap":14015073071},{"date":"2026-03-13","current":299.287031,"twenty":402.338985,"median":457.528006,"eighty":481.000215,"marketCap":9464083401},{"date":"2026-03-20","current":315.053976,"twenty":397.81132,"median":454.320794,"eighty":480.840623,"marketCap":9924943114},{"date":"2026-03-27","current":299.095644,"twenty":391.175665,"median":451.779671,"eighty":479.42962,"marketCap":9398246299},{"date":"2026-04-02","current":3318.248683,"twenty":389.832113,"median":451.779671,"eighty":480.872541,"marketCap":9381570423},{"date":"2026-04-10","current":3321.445916,"twenty":390.816678,"median":452.984556,"eighty":482.236241,"marketCap":9463036901},{"date":"2026-04-17","current":3317.060015,"twenty":392.419904,"median":455.282385,"eighty":483.410603,"marketCap":9454509433},{"date":"2026-04-24","current":2996.4431,"twenty":394.891161,"median":460.26919,"eighty":490.336167,"marketCap":8541149514},{"date":"2026-04-30","current":3202.871531,"twenty":396.041553,"median":462.144769,"eighty":499.979081,"marketCap":9131900891},{"date":"2026-05-08","current":3148.404437,"twenty":397.173254,"median":463.774025,"eighty":508.169798,"marketCap":9007763175},{"date":"2026-05-15","current":2973.181714,"twenty":398.099028,"median":464.50673,"eighty":512.854422,"marketCap":8528814526},{"date":"2026-05-22","current":2811.882705,"twenty":399.495195,"median":466.720409,"eighty":2921.871357,"marketCap":8047680823},{"date":"2026-05-29","current":3180.044455,"twenty":400.476536,"median":467.247998,"eighty":2926.706614,"marketCap":9133017429},{"date":"2026-06-01","current":3038.815931,"twenty":400.575047,"median":467.575731,"eighty":2963.886694,"marketCap":8746652155}],"updateTime":1780422376486},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02652\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1185911468","title":"CF PharmTech Signs Three-Year Strategic Partnership with JD Health for Exclusive Online Launch of Respiratory Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=1185911468","media":"Bulletin Express","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185911468?lang=en_us&edition=fundamental","pubTime":"2026-03-23 08:21","pubTimestamp":1774225287,"startTime":"0","endTime":"0","summary":"CF PharmTech, Inc. (CF PharmTech) announced that it entered into a strategic cooperation agreement with JD Health International Inc. on 20 March 2026, appointing JD Health as the exclusive online...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167098882","title":"CF PHARMTECH (02652) Enters Strategic Partnership with JD HEALTH","url":"https://stock-news.laohu8.com/highlight/detail?id=1167098882","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167098882?lang=en_us&edition=fundamental","pubTime":"2026-03-23 08:18","pubTimestamp":1774225105,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) has announced the formal signing of a strategic cooperation agreement with JD Health International Inc. (JD HEALTH) on March 20, 2026. Under this agreement, JD HEALTH will serve...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1191","BK1247","LU0051755006.USD","BK1583","06618","86618","LU0456827905.SGD","SGXZ62798434.SGD","SGXZ86797644.SGD","BK1591","BK1589","BK1571","BK1615","BK1142","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621956747","title":"CF PharmTech Taps JD Health as Exclusive Online Partner for New Respiratory Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2621956747","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621956747?lang=en_us&edition=fundamental","pubTime":"2026-03-23 08:07","pubTimestamp":1774224434,"startTime":"0","endTime":"0","summary":"CF PharmTech. Inc. Class H ( ($HK:2652) ) has shared an announcement. CF PharmTech, Inc., a PRC-based innovator in inhalation drug delivery, focuse...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cf-pharmtech-taps-jd-health-as-exclusive-online-partner-for-new-respiratory-drugs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cf-pharmtech-taps-jd-health-as-exclusive-online-partner-for-new-respiratory-drugs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HK0000320264.USD","BK4524","BK4614","BK4558","BK4579","IE0008368742.USD","86618","LU0588546209.SGD","BK4526","BK4122","LU1688375341.USD","HK0000306701.USD","BK4220","LU0244354667.USD","BK4551","HK0000320223.HKD","LU1188198961.HKD","BK4588","LU1880383366.USD","BK4531","HK0000306685.HKD","SG9999002463.SGD","BK4093","BK4504","BK4503","BK4505","LU0307460666.USD","KJD","BK4509","LU0326950275.SGD","LU0106959298.USD","02652","IE00BGV7N243.SGD","BK4585","09618","LU0463099449.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621747893","title":"CF PharmTech signs strategic cooperation agreement with JD Health International Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2621747893","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621747893?lang=en_us&edition=fundamental","pubTime":"2026-03-23 08:04","pubTimestamp":1774224298,"startTime":"0","endTime":"0","summary":"CF PharmTech signed a strategic cooperation agreement with JD Health on March 20, 2026.JD Health will act as the exclusive online launch platform for several new respiratory and rhinology products over the next three years.Support under the agreement includes online launch sales and patient services, plus prescription management and patient administration.The parties will also explore internet-based chronic disease management models.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CF Pharmtech Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 23, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nNDL64hRqB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0488056044.USD","LU0456846285.SGD","LU0348825331.USD","LU0865486749.SGD","LU0140636845.USD","JD","LU0588545730.USD","LU0163747925.USD","LU0868486357.SGD","LU0315178854.USD","BK1142","LU1808992512.USD","LU0051755006.USD","LU0708995583.HKD","LU1282651048.USD","LU1282651121.HKD","LU0499858438.USD","LU1366334651.USD","LU0359202008.SGD","89618","LU0345776255.USD","SGXZ62798434.SGD","LU0320764755.SGD","SG9999002562.SGD","BK1583","LU0370786039.SGD","LU1794554557.SGD","LU0149721374.USD","SG9999001226.SGD","BK1191","BK1588","LU2242644610.SGD","LU1720050803.USD","LU0543330483.HKD","LU0164865239.USD","LU1044875133.USD","LU0228367735.SGD","LU0315179316.USD","LU0417516738.SGD","LU0871576103.HKD","LU1719994722.HKD","LU1251922891.USD","LU0828237510.HKD","LU0359201612.USD","LU0039217434.USD","LU0348805143.USD","LU0572944931.SGD","LU0672654166.SGD","LU0320764599.SGD","LU0384037296.USD","02652","BK1615","LU0588546209.SGD","BK1619","LU0228659784.USD","LU0650527681.SGD","LU0791590937.USD","IE00BGV7N243.SGD","LU0431992006.USD","LU2039709279.SGD","IE00B29SXG58.USD","LU0588545490.SGD","BK1610","LU0084288322.USD","BK1591","LU0128522157.USD","LU0048580855.USD","BK1589","LU0211977185.USD","86618","LU1023057109.AUD","LU1282649067.USD","LU1224444064.USD","BK1249","LU0259732245.USD","LU0327786744.USD","LU1481107354.HKD","LU0231483743.USD","LU0456827905.SGD","LU1282649810.SGD","SG9999002828.SGD","BK1247","LU0307460666.USD","LU0469268626.HKD","LU0499858602.USD","LU0345775950.USD","LU2257852520.SGD","SGXZ86797644.SGD","LU0052750758.USD","LU1813983027.USD","LU0594300419.USD","BK1515","IE00B3M56506.USD","LU0456842615.SGD","LU0791591158.USD","BK1571","LU1770036033.HKD","LU1044876610.USD","LU0314109678.HKD","LU0164880469.USD","LU0348735423.USD","LU0531971595.HKD","LU0588545904.SGD","LU1303224171.USD","LU1770034418.SGD","LU0293314216.USD","LU1328277881.USD","LU0029875118.USD","LU1044874839.SGD","06618","LU1642822792.SGD","LU1366334578.USD","LU0359201885.HKD","IE0032431581.USD","BK1575","LU0417516902.SGD","BK1502"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2621747895","title":"CF Pharmtech Inc - JD Health to Be Exclusive Online Launch Platform for Major New Products for Three Years","url":"https://stock-news.laohu8.com/highlight/detail?id=2621747895","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621747895?lang=en_us&edition=fundamental","pubTime":"2026-03-23 08:04","pubTimestamp":1774224287,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nFWN40A030:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135163379","title":"CF PHARMTECH (02652) Forecasts 2025 Adjusted Net Profit of RMB 30-35 Million, Highlights Steady Operations and R&D Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=1135163379","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135163379?lang=en_us&edition=fundamental","pubTime":"2026-03-21 00:42","pubTimestamp":1774024943,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) has announced that the Group's overall business operations remain normal, maintaining profitability for three consecutive years. The Group anticipates achieving the following for...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108040015","title":"CF PharmTech issues profit warning: 2025 revenue projected to fall to RMB410-450 million, net profit to narrow to RMB2-3 million","url":"https://stock-news.laohu8.com/highlight/detail?id=1108040015","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108040015?lang=en_us&edition=fundamental","pubTime":"2026-03-20 22:43","pubTimestamp":1774017839,"startTime":"0","endTime":"0","summary":"CF PharmTech, Inc. has warned shareholders that both revenue and earnings for the year ending 31 December 2025 will contract sharply, according to a preliminary review of unaudited management...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620732987","title":"CF Pharmtech - Expected Result Due Reduction in Average Selling Price of Group's Product CF017, Others in FY","url":"https://stock-news.laohu8.com/highlight/detail?id=2620732987","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620732987?lang=en_us&edition=fundamental","pubTime":"2026-03-20 22:31","pubTimestamp":1774017062,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260320:nFWN4080GK:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620732629","title":"CF PharmTech forecasts 2025 revenue of RMB410 million to RMB450 million and net profit of RMB2 million to RMB3 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2620732629","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620732629?lang=en_us&edition=fundamental","pubTime":"2026-03-20 22:30","pubTimestamp":1774017052,"startTime":"0","endTime":"0","summary":"CF Pharmtech expects revenue of RMB410 million to RMB450 million, compared with RMB607.75 million previously.Net profit attributable to shareholders is forecast at RMB2 million to RMB3 million under IFRS, versus RMB21.09 million previously.Adjusted net profit  is expected to be RMB30 million to RMB35 million, compared with RMB51.87 million previously.Key factors cited include a lower average selling price for CF017 after volume-based procurement renewal and higher R&D spending on innovative drugs.Additional factors cited include weaker demand linked to fewer respiratory infections and one-off listing expenses affecting IFRS net profit.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CF Pharmtech Inc. published the original content used ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260320:nNDL3L2JL7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174851335","title":"CF PHARMTECH (02652) Schedules 30 March 2026 Board Meeting to Approve FY 2025 Results and Final Dividend Proposal","url":"https://stock-news.laohu8.com/highlight/detail?id=1174851335","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174851335?lang=en_us&edition=fundamental","pubTime":"2026-03-18 16:42","pubTimestamp":1773823378,"startTime":"0","endTime":"0","summary":"CF PHARMTECH, Inc. (Stock Code: 02652) has set 30 March 2026 for a board meeting to review and approve the consolidated financial results for the fiscal year ended 31 December 2025. The agenda also...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620355502","title":"CF PharmTech board to review FY2025 annual results and final dividend proposal","url":"https://stock-news.laohu8.com/highlight/detail?id=2620355502","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620355502?lang=en_us&edition=fundamental","pubTime":"2026-03-18 16:31","pubTimestamp":1773822665,"startTime":"0","endTime":"0","summary":"CF Pharmtech’s board will meet on March 30, 2026 to consider and approve the group’s annual results for the year ended December 31, 2025. The board will also consider a recommendation on a final dividend at the March 30, 2026 meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CF Pharmtech Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 18, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDLcfs3QB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181630658","title":"Hong Kong Market Midday Review: Hang Seng Index Dips 0.17% While AI Model Concept Stocks Climb Against Trend","url":"https://stock-news.laohu8.com/highlight/detail?id=1181630658","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181630658?lang=en_us&edition=fundamental","pubTime":"2026-03-18 12:11","pubTimestamp":1773807063,"startTime":"0","endTime":"0","summary":"The Hang Seng Index declined by 0.17%, shedding 43 points to reach 25,824 points in morning trading. The Hang Seng Tech Index dropped by 0.81%. Morning session turnover on the Hong Kong market...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"d0f3c5bccb622a532fbc5668691928ff","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0359201885.HKD","LU1303224171.USD","ZTO","LU0210526637.USD","LU0211977185.USD","BK1608","LU0572944931.SGD","LU0327786744.USD","513600","06088","06809","BK1117","LU1251922891.USD","81024","HTImain","LU1188198961.HKD","GDS","LU1720050803.USD","BK1095","BK1615","KSTmain","HSI","LU1719994722.HKD","00667","02833","LU0359202008.SGD","600026","LU0588546209.SGD","HSTECH","09698","HSImain","BK1575","BK4588","LU0348767384.USD","LU0456827905.SGD","LU1770034418.SGD","BK4585","LU0359201612.USD","02057","MCHmain","00100","LU2097828805.USD","LU1023057109.AUD","LU0463099449.HKD","03986","BK1591","LU1794554557.SGD","03858","LU0051755006.USD","LU0244354667.USD","BK1590","LU0348766576.USD","LU2097828714.EUR","LU0140636845.USD","603986","LU2097828557.USD","LU2097828631.EUR","688008","LU0307460666.USD","02652","01138","BK1610","HHImain","LU2097828474.EUR","LU0593848301.USD","LU0326950275.SGD","02513"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1105666137","title":"CF PHARMTECH (02652) Surges Over 21% in Intraday Trading as Advanced Respiratory Pipeline Accelerates Towards Harvest Phase","url":"https://stock-news.laohu8.com/highlight/detail?id=1105666137","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105666137?lang=en_us&edition=fundamental","pubTime":"2026-03-18 10:14","pubTimestamp":1773800059,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) saw its shares rise more than 21% during the morning session. At the time of writing, the stock was up 14.54%, trading at HK$28.2, with a turnover of HK$81.96 million. The surge...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK4585","VXUS","BK4588","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619884451","title":"CF Pharmtech IND application for ICF001 accepted by China’s NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=2619884451","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619884451?lang=en_us&edition=fundamental","pubTime":"2026-03-16 18:09","pubTimestamp":1773655750,"startTime":"0","endTime":"0","summary":"China’s NMPA accepted CF Pharmtech’s IND application for ICF001, an inhaled powder drug candidate. The regulatory review covers treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab62decfe9624416502f0a5b97418c66","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nNDL6yd8t:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619459042","title":"Major Milestone CF Pharmtech, Inc. 2652.HK Announces Ind Acceptance for Pah New Drug With a Globally Innovative Improved Mechanism, Marking Another Milestone for Its Precision Drug Delivery Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2619459042","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619459042?lang=en_us&edition=fundamental","pubTime":"2026-03-16 18:08","pubTimestamp":1773655738,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nTUC1KMF2D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619802434","title":"BUZZ-CF PharmTech jumps most on record on new hypertension drug application","url":"https://stock-news.laohu8.com/highlight/detail?id=2619802434","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619802434?lang=en_us&edition=fundamental","pubTime":"2026-03-16 10:36","pubTimestamp":1773628582,"startTime":"0","endTime":"0","summary":"BUZZ-CF PharmTech jumps most on record on new hypertension drug application** Shares of China-based inhalation technologies and drugs developer CF PharmTech Inc 2652.HK soar 37.6% to HK$31.64; on course for the biggest one-day pct gain since debut on October 8** Stock hits the highest since March 10** Company said China's National Medical Products Administration had accepted investigational new drug  application for its inhalation powder candidate ICF001 to treat pulmonary hypertension and related pulmonary diseases** ICF001 possesses broad potential to expand into larger patient populations, such as those with pulmonary fibrosis associated with interstitial lung disease, in the future - Co** YTD, stock down 12.9%, while Hang Seng Biotech Index .HSBIO up 0.3%  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nL1N40402C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136164556","title":"CF PHARMTECH (02652) Surges Over 17% as IND for Novel Pulmonary Hypertension Drug is Accepted","url":"https://stock-news.laohu8.com/highlight/detail?id=1136164556","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136164556?lang=en_us&edition=fundamental","pubTime":"2026-03-16 10:08","pubTimestamp":1773626908,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) saw its shares rise more than 17%. At the time of writing, the stock was up 16.43%, trading at HK$26.78, with a turnover of HK$12.2058 million. On the news front, on March 13, CF...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab62decfe9624416502f0a5b97418c66","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","LU1988902786.USD","LU0256863811.USD","LU0208291251.USD","VXUS","BK4580","LU0211331839.USD","LU0417517546.SGD","LU1989772840.SGD","BK4588","LU0070302665.USD","BK4161","LU2264538146.SGD","LU0320765489.SGD","LU1064131342.USD","02652","LU1989772923.USD","LU0256863902.USD","BK4585","IND","PH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120165890","title":"CF PHARMTECH (02652): NMPA Accepts IND Application for Inhalation-Powder Candidate ICF001","url":"https://stock-news.laohu8.com/highlight/detail?id=1120165890","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120165890?lang=en_us&edition=fundamental","pubTime":"2026-03-13 21:21","pubTimestamp":1773408119,"startTime":"0","endTime":"0","summary":"Hong Kong – CF PharmTech, Inc. (stock code: 02652) announced that the National Medical Products Administration (NMPA) has formally accepted the Investigational New Drug (IND) application for its...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126576438","title":"CF PHARMTECH (02652) Receives NMPA Acceptance for IND Application of Self-Developed Inhalation Powder ICF001","url":"https://stock-news.laohu8.com/highlight/detail?id=1126576438","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126576438?lang=en_us&edition=fundamental","pubTime":"2026-03-13 21:06","pubTimestamp":1773407187,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) has announced that the Investigational New Drug (IND) application for its self-developed inhalation powder candidate, ICF001, has been accepted by the National Medical Products...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619197090","title":"CF PharmTech says NMPA accepts IND application for ICF001 inhalation powder","url":"https://stock-news.laohu8.com/highlight/detail?id=2619197090","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619197090?lang=en_us&edition=fundamental","pubTime":"2026-03-13 21:04","pubTimestamp":1773407089,"startTime":"0","endTime":"0","summary":"CF Pharmtech said China’s National Medical Products Administration accepted its investigational new drug application for ICF001, an inhalation powder candidate. The filing is for pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease. The applicant is CF Pharmtech Guangzhou, a subsidiary of the company.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CF Pharmtech Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 13, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nNDLbrycGY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":185,"code":"91000000","status":"200"}]}}